Feed 2487.HK
24
Cutia Therapeutics
2487.HK · HKSE
$2.53 -2.32% (-$0.06)
1M -5.95%
Market Cap ¥791.5M
P/E Ratio -
Div. Yield -
ROE 35.76%
Valuation
84 /100
Cheap P/S 2.35x
P/B 0.89x
P/E N/A
Growth
100 /100
Growing Rev. growth 209.25%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 58.25%
FCF margin 90.13%
Net margin 101.20%
Quality
3 /100
Poor ROIC 25.65%
Asset turnover 0.26x
ROE 35.76%
Debt
67 /100
Low Debt/Equity 0.36x
Int. coverage -32.62x
Current ratio 3.87x
Stability
26 /100
Unstable Beta 0.49x
Profitable years 0
Rev. volatility 607.14%
Vprašajte StockBota o 2487.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Lele Zhang
Employees
304
Headquarters
Shanghai
Prihajajoči dogodki
27 AVG.
Earnings
Upcoming earnings report